PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Takis s.r.l, Via di Castel Romano 100, 00128, Rome, Italy.\', \'Evvivax s.r.l, Via di Castel Romano, 100, 00128, Rome, Italy.\', \'Takis s.r.l, Via di Castel Romano 100, 00128, Rome, Italy. marra@takisbiotech.it.\', \'Evvivax s.r.l, Via di Castel Romano, 100, 00128, Rome, Italy. marra@takisbiotech.it.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1186/s12967-020-02392-y
?:doi
?:hasPublicationType
?:journal
  • Journal of translational medicine
is ?:pmid of
?:pmid
?:pmid
  • 32493510
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.565
?:rankingScore_hIndex
  • 81
?:title
  • SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all